EyeGene Inc. 185490.KQ Stock
EyeGene Inc. Price Chart
EyeGene Inc. 185490.KQ Financial and Trading Overview
| EyeGene Inc. stock price | 2650 KRW |
| Previous Close | 4425 KRW |
| Open | 4415 KRW |
| Bid | 4415 KRW x N/A |
| Ask | 4420 KRW x N/A |
| Day's Range | 4410 - 4530 KRW |
| 52 Week Range | 4140 - 11650 KRW |
| Volume | 32.81K KRW |
| Avg. Volume | 123.03K KRW |
| Market Cap | 48.48B KRW |
| Beta (5Y Monthly) | 1.958174 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
185490.KQ Valuation Measures
| Enterprise Value | 48.47B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.2390175 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.238 |
| Enterprise Value/EBITDA | -1.519 |
Trading Information
EyeGene Inc. Stock Price History
| Beta (5Y Monthly) | 1.958174 |
| 52-Week Change | -49.020% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11650 KRW |
| 52 Week Low | 4140 KRW |
| 50-Day Moving Average | 4578.1 KRW |
| 200-Day Moving Average | 5790.33 KRW |
185490.KQ Share Statistics
| Avg. Volume (3 month) | 123.03K KRW |
| Avg. Daily Volume (10-Days) | 64.38K KRW |
| Shares Outstanding | 10.99M |
| Float | 19.29M |
| Short Ratio | N/A |
| % Held by Insiders | 10.20% |
| % Held by Institutions | 1.77% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -700.013% |
| Gross Margin | 48.59% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.66% |
| Return on Equity (ttm) | -50.85% |
Income Statement
| Revenue (ttm) | 4.73B KRW |
| Revenue Per Share (ttm) | 220.86 KRW |
| Quarterly Revenue Growth (yoy) | 91.10% |
| Gross Profit (ttm) | 1.47B KRW |
| EBITDA | -31907620864 KRW |
| Net Income Avi to Common (ttm) | -46328541184 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.05B KRW |
| Total Cash Per Share (mrq) | 3308.14 KRW |
| Total Debt (mrq) | 2.4B KRW |
| Total Debt/Equity (mrq) | 3.35 KRW |
| Current Ratio (mrq) | 13.039 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26614630400 KRW |
| Levered Free Cash Flow (ttm) | -19516463104 KRW |
Profile of EyeGene Inc.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | B-910, 401, Yangcheon-ro |
| ZIP | 07528 |
| Phone | 82 2 322 1687 |
| Website | https://www.eyegene.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 76 |
EyeGene Inc., a biotechnology company, engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea. The company's products in pipeline include EG-Mirotin, a Phase IIa clinical trial product candidate for the treatment of diabetic retinopathy; EG-Decorin, a Phase I/II clinical trial product for the treatment for pressure ulcers; EG-Myocin, a product that is in Phase II clinical trials for the treatment of heart muscle; and EG-HPV, a product that completed Phase I clinical trial for the treatment of cervical cancer. Its products in pipeline also include EG-TB for the treatment of tuberculosis; and EG-HZ, which is in preclinical trials for the treatment of herpes zoster. EyeGene Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Q&A For EyeGene Inc. Stock
What is a current 185490.KQ stock price?
EyeGene Inc. 185490.KQ stock price today per share is 2650 KRW.
How to purchase EyeGene Inc. stock?
You can buy 185490.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EyeGene Inc.?
The stock symbol or ticker of EyeGene Inc. is 185490.KQ.
How many shares does EyeGene Inc. have in circulation?
The max supply of EyeGene Inc. shares is 27.03M.
What is EyeGene Inc. Price to Earnings Ratio (PE Ratio)?
EyeGene Inc. PE Ratio is now.
What was EyeGene Inc. earnings per share over the trailing 12 months (TTM)?
EyeGene Inc. EPS is 0 KRW over the trailing 12 months.
EyeGene Inc. 185490.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 842.12 KRW 0.64 USD |
+0.02
|
704.56K KRW 532 USD | 839.34 KRW 0.63 USD | 846.76 KRW 0.64 USD | — - | 704.56K KRW 532 USD |
| Kosdaq Small Index KQSM | 2717.9 KRW 2.05 USD |
+0.23
|
409.18K KRW 309 USD | 2713.32 KRW 2.05 USD | 2723.66 KRW 2.06 USD | — - | 409.18K KRW 309 USD |
| Kosdaq Other Services Index KQ16 | 4027.13 KRW 3.04 USD |
-1.32
|
41.56K KRW 31 USD | 3988.8 KRW 3.01 USD | 4081.16 KRW 3.08 USD | — - | 41.56K KRW 31 USD |
- {{ link.label }} {{link}}